Navigation Links
Moderate drinking can reduce risks of Alzheimer's dementia and cognitive decline
Date:12/29/2008

MAYWOOD, Ill. -- Moderate drinkers often have lower risks of Alzheimer's disease and other cognitive loss, according to researchers who reviewed 44 studies.

In more than half of the studies, published since the 1990s, moderate drinkers of wine, beer and liquor had lower dementia risks than nondrinkers. In only a few studies were there increased risks.

"Alcohol is a two-edged sword," said Michael Collins, Ph.D., a professor and neuroscientist at Loyola University Chicago Stritch School of Medicine and lead author of the refereed report in the journal Alcoholism: Clinical and Experimental Research. "Too much is bad. But a little might actually be helpful."

Moderate alcohol consumption generally is defined as 1 drink or less per day for women and 1-2 drinks or less per day for men.

The article will be published in the February 2009 issue of the journal, and is available on line now. The article summarizes a roundtable, organized by Collins, held at the Research Society on Alcoholism meetings in Chicago in 2007.

"The pathological damage and vast social havoc from addiction to and abuse of alcohol are well known, and of necessity should continue to receive primary attention by doctors, scientific researchers and health professionals," Collins and colleagues write. "However, light-to-moderate responsible alcohol consumption "appears to carry certain health benefits."

Long-term alcohol abuse can cause memory loss and impair cognitive function. It's unknown why moderate alcohol use appears to have the opposite effect. One theory is that the well-known cardiovascular benefits of moderate alcohol consumption also can reduce the risk of mini strokes that cause dementia.

Collins and another Loyola professor, neuroscientist Edward Neafsey, Ph.D., suggest a second possible explanation. Small amounts of alcohol might, in effect, make brain cells more fit. Alcohol in moderate levels stresses cells and thus t
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
2. FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause
3. FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
4. Can rectal vitamin E induce remission in patients with mild to moderate ulcerative colitis?
5. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
6. SEAL Indiana Reports More Than Half of Indianapolis Area School Kids Treated by Program Have Moderate or Severe Dental Decay
7. Moderate Aerobics May Ease Insomnia Symptoms
8. Drug Works Well for Moderate-to-Severe Psoriasis
9. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
10. Ad in USA TODAY Touts Benefits of Moderate UV Exposure
11. Moderate alcohol consumption in middle age can lower cardiac risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Lawyers from The Healy Law Fi...t in Illinois on behalf of man rendered an incompl...go, IL (Lexis Nexis) November 30, 2009 -- A Cook C...favor of an Irish immigrant carpenter, 22 years ol...as rendered an incomplete quadriplegic. The verdi...
(Date:11/30/2009)... , CHICAGO, Nov. 30 Three deca...abs were being swallowed by children, prompting a ...tudy presented today at the annual meeting of the ... that the new tabs are still potentially unsafe. ,...e in beverage can construction in the U.S. was to ...
(Date:11/30/2009)...CAGO Middle-aged men and women who engage in high...using damage to their knees and increasing their r...nted today at the annual meeting of the Radiologic...suggest that people with higher physical activity ...abnormalities and, thus, at higher risk for develo...
(Date:11/30/2009)...ALLAS Nov. 30, 2009 UT Southwestern Medical Cent... help families stave off complications associated ... the December issue of Pediatrics, suggest that ...hmatic children who have received specialized topi...hma attacks, emergency room visits and missed adul...
(Date:11/29/2009)... The Academy of General Dentis...ge county CA, received the Mastership Award during...s AGD members, commitment to excellence in dental ...ed 1,100 hours of approved continuing dental educa... 400 hours dedicated to hands-on skills and techni...
Breaking Medicine News(10 mins):Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 3Health News:Beverage Can Stay-Tabs Pose Swallowing Risk 2Health News:Too much physical activity may lead to arthritis 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2
... survival rate of breast cancer patients by 63 per...rd regimes available . The clinical trial strength...mestane, as a first option.// A study showed that ...ears of tamoxifen treatment. According to the ...
... 6 million Americans are allergic to fish and shel...r ‘convincing allergy’ // to seafood is reported b...about 6.5 million Americans.” In a recent stud... households to determine the prevalence of self-re...
...tific evidence that mental stress alone can trigge...bances // in normal heart rhythm. Researchers stud...were under mental and physical stress. They includ...cent incident that made them angry and also by hav...
...n extreme pain that can last for months. Now a sim..., up to 14,000 people // over age 60 develop shing...hicken pox virus. A new study shows tai chi -- ...n shown to help illnesses such as Parkinson's dise...
...y researchers shows young breast cancer survivors ...patients. // As patients may not be getting the ap...math of the disease. Researchers sampled nearly... that 65 percent of the respondents were still und...
...e of antidepressants in children is increasing at ...gs are not safe // and may actually increase a chi...nalyzed drug prescriptions written for more than 5... selective serotonin reuptake inhibitor ( SSRI ) s...
Other Medicine News:
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Med...shed ultrasound solutions, will showcase leading u...p, GE Logiq I and Siemens X300 Premium Edition dur...ety of North America (RSNA) conference, being held...sin-based MedPro Imaging markets ultrasound produc...
(Date:11/30/2009)..., , WAYNE, N.J. and CHICAGO, Nov. 30 /PRN...and Annual Meeting of the Radiological Society o...ticals Inc. announced the enrollment of the first ...al to evaluate the efficacy and safety of florbeta...beta-Amyloid plaques in the brain, which are a pat...
(Date:11/30/2009)..., , INDIANAPOLIS, Nov. 30 /PRNews...ration (FDA) has approved Cymbalta® (duloxeti...ed anxiety disorder (GAD) in adults, Eli Lilly and...nce generalized anxiety disorder can be a chronic ...tients find a treatment option that is effective i...
Breaking Medicine Technology:MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 1Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 2Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 3Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St John Wound Center 12693 4Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 1Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 2Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 3Stroke survivors report loss of sexual desire blurred gender roles anger and fatigue 49357 4Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 1Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 2Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 3Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders 49353 4
...nificance , , ISELIN, N.J., Nov. 19 Pharmos...ults from its Phase 2a clinical trial of its topic...ulated with 3% Diclofenac Diethanolamine. , , ...cebo-controlled study evaluated the safety and eff...e NanoEmulsion cream in 104 patients with chronic ...
...lopment and,manufacturing organization for sterile...f its contract facility in Delaware. Isogen was fo...y and capacity problems commonly,associated with t...nd,early-stage commercial sterile filling market s...lion and four years to develop sterile,manufacturi...
Other Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2
Rotanta 460S
Lens Center Rotary
4 Frame Floating Display
1 Frame Eye Vee 2.0 Clear Display
Medicine Products: